RARS1 and neoplasm: Together, these data demonstrate that RARS1-expressing tumor cells orchestrate macrophage polarization toward an immunosuppressive, M2-like state, whereas the loss of RARS1 disrupts this crosstalk and promotes a shift toward a proinflammatory, antitumor macrophage phenotype.